Avalo Therapeutics, Inc. (AVTX)
NASDAQ: AVTX · Real-Time Price · USD
8.46
-0.27 (-3.09%)
At close: Mar 28, 2025, 4:00 PM
8.52
+0.06 (0.69%)
After-hours: Mar 28, 2025, 7:50 PM EDT
Avalo Therapeutics Market Cap
Avalo Therapeutics has a market cap or net worth of $90.28 million as of March 28, 2025. Its market cap has increased by 1,951.92% in one year.
Market Cap
90.28M
Enterprise Value
-43.34M
1-Year Change
1,951.92%
Ranking
Category
Stock Price
$8.46
Market Cap Chart
Since November 13, 2015, Avalo Therapeutics's market cap has increased from $34.50M to $90.28M, an increase of 161.69%. That is a compound annual growth rate of 10.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 90.30M | 16.97% |
| Dec 31, 2024 | 77.20M | 957.53% |
| Dec 29, 2023 | 7.30M | -84.60% |
| Dec 30, 2022 | 47.40M | -75.17% |
| Dec 31, 2021 | 190.90M | -3.49% |
| Dec 31, 2020 | 197.80M | -16.79% |
| Dec 31, 2019 | 237.70M | 80.35% |
| Dec 31, 2018 | 131.80M | 58.03% |
| Dec 29, 2017 | 83.40M | 917.07% |
| Dec 30, 2016 | 8.20M | -71.63% |
| Dec 31, 2015 | 28.90M | -16.23% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 737.85B |
| UnitedHealth Group | 471.74B |
| Johnson & Johnson | 393.12B |
| AbbVie | 358.61B |
| Novo Nordisk | 308.71B |
| Abbott Laboratories | 227.80B |
| AstraZeneca | 225.00B |
| Merck & Co. | 221.28B |